Hansa Medical trades up after €66m block

Pills_230px
By Aidan Gregory, Sam Kerr
14 Nov 2018

In an otherwise barren week for block trades, Hansa Medical, the Swedish biotechnology company, raised Skr399.8m of fresh capital to fund product development. The deal also provided an opportunity for Nexttobe AB to sell a portion of its stake in the company.

Cowen & Co, RBC Capital Markets and SEB were bookrunners.

The deal consisted of 1.77m new shares and 888,382 shares sold by Nexttobe, the largest shareholder in Hansa. It was priced at Skr225, a 16.6% discount to the closing price of Hansa on Tuesday, valuing the sale ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.